0143-9391-10 · Remifentanil Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.
What is the status for 0143-9391-10 · Remifentanil Hydrochloride Injection · Hikma Pharmaceuticals USA, Inc.?
For 0143-9391-10, generic name is Remifentanil Hydrochloride Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable; fda note is Estimated recovery: TBD, recorded from its source on 2026-11-04.
"initial_posting_date": "06/28/2022", "package_ndc": "0143-9391-10", "generic_name": "Remifentanil Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 0143-9391-10 verified
- Generic name
- Remifentanil Hydrochloride Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Estimated recovery: TBD verified
- Initial posting date
- 06/28/2022 verified
- Last update date
- 10/14/2026 verified
- Days in shortage
- 1590 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Analgesia/Addiction verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "10/14/2026", "therapeutic_category": [ "Analgesia/Addiction" ], "dosage_form": "Injection", "presentation": "Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000